Bharat Bio successfully completes Phase III trials of new oral...

Dununu.com Dununu

Commandité

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

RSS Feed National

Posté

147

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.

Read Full Article

Connectez-vous pour aimer, partager et commenter!

IND vs ENG 3rd Test: Workload or lack of support?

Jasprit Bumrah's workload management has sparked debate, contrasting with Kapil Dev's era....

Par 0 4

Aditya 's Metro In Dino Set to Surpass Ok Jaanu's Lifetime Collection

Aditya Roy Kapur's Metro In Dino performs well. The film earns Rs 22.15 crore in five days. It...

Par 0 7

AIIMS INI SS second round seat allotment result 2025 declared at aiimsexams.ac.in: Direct link to download here

Par 0 19

IND vs ENG: 'Who would want to be a bowler?' – Pat Cummins slams Edgbaston pitch with nearly 1700 runs scored

Following India's dominant 336-run victory over England at Edgbaston, Australia's captain Pat...

Par 0 21

IND vs ENG 3rd Test: Upbeat Bumrah goes through the paces at Lord's

Ahead of the third Test at Lord's, Jasprit Bumrah fine-tuned his bowling with subtle adjustments...

Par 0 19